No Priors: Artificial Intelligence | Technology | Startups cover image

Chai-2: The AI Model Accelerating Drug Discovery with Chai Discovery Co-Founders Jack Dent and Joshua Meier

No Priors: Artificial Intelligence | Technology | Startups

00:00

A Breakthrough in Antibody Design with CHI 2

This chapter highlights a breakthrough in the CHI 2 model, enhancing antibody design with a remarkable 20% success rate in binding to targets. It emphasizes the potential of this method to transform drug discovery and provide access to previously inaccessible therapeutic targets.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app